The creation of the Rheum4Science program grew out of the conviction that teaching science is important for rheumatologists in training and that adult learners benefit from a variety of resources and formats. The Rheum4Science: Immunology Series provides a progressive, clinically focused foundation in immunology for emerging rheumatology clinicians.Participants will explore innate and adaptive immune mechanisms and their relevance to rheumatologic disease, strengthening diagnostic insight and clinical decision‑making.Rheum4Science SeriesThis activity is part of a series. See the other activities in the series below.Rheum4Science: Immunology SeriesRheum4Science: Pathology SeriesRheum4Science Interactive ModulesRheum4Science – Clinical Research MethodologyRheum4Science: Data & DistributionRheum4Science: Cohort StudiesRheum4Science: Randomized Controlled TrialsRheum4Science – Immunopathogenesis of Rheumatic DiseaseRheum4Science: Pathogenesis of Rheumatoid ArthritisRegistration is complimentary.Target AudienceRheumatology fellows in training. This activity may also be of interest to medical students, residents, practicing rheumatologists, and other rheumatology health care professionals interested in strengthening their understanding of basic scientific principles and clinical research methodology relevant to the field of rheumatology. Learning ObjectivesUpon completion of this activity, participants should be able to: Explain the core organization and principles of the immune system, including recognition, activation, regulation, and memory in health and diseaseDifferentiate innate and adaptive immune responses, including their key cells, mediators, effector mechanisms, and timingDescribe how immune responses are initiated and shaped, including pattern recognition, antigen processing and presentation, and immune signaling pathwaysSummarize the roles of key immune cells and mediators, including dendritic cells, neutrophils, cytokines, complement, T cells, B cells, and antibodiesExplain how immune responses are anatomically organized, including lymphoid organs, immune compartments, and cellular traffickingRecognize mechanisms of immune dysregulation that contribute to autoimmunity, autoinflammatory disease, and immune‑mediated tissue injuryApply foundational immunologic concepts to clinical reasoning in rheumatology, supporting diagnostic interpretation and therapeutic decision‑makingCE & MOC InformationThis activity is not eligible for CE/MOC.Acknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewThe Pediatric Rheumatology Symposium (PRSYM) Highlights will provide up-to-date, practical clinical information and basic science knowledge on the diagnosis and management of pediatric patients with rheumatic diseases and immune disorders.TopicsAddressing Key Issues in Pediatric Rheumatology My Life as a History Lesson and a Call to ActionCourtney Wells, PhD, MPH, MSWA Different World—Viewing Pediatric Rheumatology through a Global LensLaura Lewandowski, MD, MSc Minding the Gap: Understanding and Addressing Representativeness and Disparities in Pediatric Rheumatology ResearchJennifer Woo, PhD, MPHGeneral Pediatric and Subspecialty Workforce Challenges and Potential SolutionsSpeaker: Colleen Correll, MD, MPHPanel DiscussionCourtney Wells, PhD, MPH, MSW; Laura Lewandowski, MD, MSc; Jennifer Woo, PhD, MPH; Colleen Correll, MD, MPHClinical ManagementHarnessing AIBella Mehta, MDFrom Promise to Practice: The Evolving Biosimilar Landscape in Pediatric RheumatologyIngrid Pan, PharmDWhat Do We Know About Vaccinations in Kids with Inflammatory Rheumatic Diseases?Merav Heshin-Bekenstein, MDSystemic Lupus ErythematosusPediatric Antiphospholipid Syndrome: A Few Bad aPLsJacqueline Madison, MDHitting the Target: Optimizing Outcomes in Childhood LupusEve Smith, MD, PhD, BSc Multitarget Therapy is Necessary for the Treatment of cSLE: A Great DebateHermine Brunner, MD, MSc, MBA, FAAP, FACR; and Aimee Hersh, MD, MSJuvenile Idiopathic ArthritisNot So Silent After All—Demystifying the Temporomandibular JointMarinka Twilt, MD, PhD, MSc From Clues to Clarity: Axial Disease in Juvenile SpondyloarthritisPam Weiss, MDImaging as a Biomarker: Peripheral Joint Insights in JIAPatricia Vega-Fernandez, MD, RhMSUS, MSc Panel DiscussionPam Weiss, MD; Marinka Twilt, MD, PhD, MSc; Patricia Vega-Fernandez, MD, RhMSUS, MScClinical Update - Guidlines & RecommendationsUveitis: Clinical Trials & PROsSheila Angeles Han, MD, MSc Mental Health Guidance StatementsTamar Rubinstein, MD, MS Juvenile Dermatomyositis and Scleroderma Let’s Strengthen our Research in JDM: How to Perform and Collect Critical Measures in Clinical PracticeKaveh Ardalan, MD, MS; Stacey Tarvin, MD, MS, FACR; Amy Rakestraw, PT, MPHGuidance for Stem Cell Therapy for Juvenile Systemic Sclerosis PatientsKathryn Torok, MDVasculitisAdvancing Pediatric ANCA-Associated Vasculitis: Insights from Collaborative Research and Emerging Clinical DataJessica Bloom, MD, MSRenal Disease and Risk Stratification in Pediatric ANCA-associated Vasculitis (AAV)—Insights from the Pediatric Vasculitis InitiativeKelly Brown, PhDQI/ImplementationHow to Integrate Data Elements into Clinical Care and Decision MakingDanielle Bullock, MD, MPHTransition ReadinessMelissa Argraves, MD, MEdPR-COIN: Improving JIA OutcomesJulia Harris, MDMental Health ScreeningMileka Gilbert, MD, PhDPanel DiscussionDanielle Bullock, MD, MPH; Melissa Argraves, MD, MEd; Julia Harris, MD; Mileka Gilbert, MD, PhDSystemic Juvenile Idiopathic ArthritisStill's Disease—EULAR/PReS Recommendations Fabrizio De Benedetti, MD, PhDIL-18 InflammosopathyScott Canna, MDCAR-T Therapy: European ExperienceFabrizio De Benedetti, MD, PhDSituational Awareness for New Passengers in the CAR(-T)Christen Ebens, MD, MPHTarget AudienceRheumatologists, rheumatology interprofessionals, fellows in training, and residents.Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Learning ObjectivesUpon completion of this activity, participants should be able to: Discuss the most up-to-date clinical information on the diagnosis and management of pediatric patients with rheumatic and immunologic disordersDescribe the most current information regarding the pathophysiology underlying pediatric rheumatic disordersCE & MOC InformationIn support of improving patient care, the American College of Rheumatology (ACR) is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.See the ACR’s CE Mission Statement. For more information, download the AMA PRA Booklet.Available CreditAMA PRA Category 1 Credit(s)™: 13.00ABIM MOC: 13.00ABP MOC: 13.00ACCME Designation StatementThe American College of Rheumatology designates this enduring material for a maximum of 13.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.MOCAfter submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for diplomates to the diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the Physician Portals. Please allow at least 48 hours for points to display in the portal. MOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 13.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. MOC Recognition Statement: American Board of Pediatrics (ABP)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 13.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. PRSYM Highlights 2026 Financial Relationship DisclosuresAcknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewYear in Review is always one of the highlights of ACR Convergence. This session provides an overview of the impactful literature published during the 12 months before Convergence. Drs. England and Davidson are leaders in clinical and basic science research of rheumatic diseases and provide a compelling overview of cutting-edge concepts in rheumatology.Target AudienceAdvanced practice nurses, fellows in training, physician assistants, residents, rheumatologists, and rheumatology interprofessionals.Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Learning ObjectivesUpon completion of this activity, participants should be able to:Discuss with a colleague key clinical papers and concepts from the previous 12 monthsDiscuss with a colleague key fundamental science papers and concepts from the previous 12 monthsCE & MOC InformationCMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.AMA Designation StatementThe American College of Rheumatology designates this Enduring Material for a maximum of 1.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by December 4, 2028, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. ACR Convergence Replay 2025: Year in Review Financial Relationship DisclosuresAcknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.

Activity OverviewACR Convergence 2025 On Demand features recorded sessions from the premier international rheumatology meeting that took place in Chicago, Illinois. See cutting-edge insights across basic and clinical science with flexible, self-paced access to plenaries and symposia. Target AudienceAdvanced practice nurses, counselors, dietitians, division directors, epidemiologists, fellows in training, health service researchers, nurses, occupational therapists, office managers/staff, pharmacists, practice administrators, primary care providers, physical therapists, physician associates, program directors, psychologists, researchers, residents, rheumatologists, rheumatology interprofessionals, social workers / community health workers, and students.Registration is discounted for ACR/ARP members. If you are not a member, consider joining ACR/ARP.Learning ObjectivesUpon completion of this activity, participants should be able to:Assess their knowledge and competence in various rheumatic diseases and conditionsSupport their skills in evaluating and diagnosing patients with rheumatic diseasesDiscuss and collaborate on challenging cases with peersAnalyze emerging trends and technologies in rheumatologyEmploy evidence-based approaches for managing rheumatic conditionsIdentify new approaches and strategies for patient managementInterpret recent clinical trial and research findingsApply new information from basic and clinical science to improve the care of people with rheumatologic illness CMEACCME Accreditation StatementThe American College of Rheumatology is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.See the ACR's CME Mission Statement. For more information, download the AMA PRA Booklet.AMA Designation StatementThe American College of Rheumatology designates this Enduring Material for a maximum of 210.00 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.CME credit must be claimed by October 24, 2026, at 11:59 PM ET.MOCMOC Recognition Statement: American Board of Internal Medicine (ABIM)Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 210.00 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.By completing this activity, you provide the ACR permission to share completion data with the ACCME and the certifying board. After submitting a reflective statement with key takeaways from the activity, MOC points will be applied for ABIM diplomates to the ABIM diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABIM Physician Portal. Please allow at least 48 hours for points to display in the portal.MOC points must be claimed by October 24, 2026, at 11:59 PM ET.MOC Recognition Statement: American Board of Pediatrics (ABP)Successful completion of this CME activity, which includes participation in the evaluation component, enables the learner to earn up to 210.00 MOC points in the American Board of Pediatrics’ (ABP) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit learner completion information to ACCME for the purpose of granting ABP MOC credit.After submitting a reflective statement with key takeaways from the meeting, MOC points will be applied for ABP diplomates to the ABP diplomate number and date of birth provided when you registered. Points are sent nightly to ACCME and then transferred to the ABP Physician Portals. Please allow at least 48 hours for points to display in the portal. MOC points must be claimed by October 24, 2026, at 11:59 PM ET.Financial Relationship DisclosuresACR Disclosure StatementIt is the policy of the American College of Rheumatology (ACR) to ensure that Continuing Medical Education (CME) activities are independent and free of commercial bias. To ensure educational content is objective, balanced, and guarantee content presented is in the best interest of its learners and the public, the ACR requires that everyone in a position to control educational content disclose all financial relationships with ineligible companies within the prior 24 months. An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. Examples can be found at accme.org.In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, ACR has implemented mechanisms prior to the planning and implementation of this CME activity to identify and mitigate all relevant financial relationships for all individuals in a position to control the content of this CME activity.Nature of Financial RelationshipsAll individuals that participate in an ACR-sponsored activity and are able to change content or influence the content of the activity must disclose to the planning committee and audience all financial or other relationships with ineligible companies including, but not limited to:Advisor or review panel memberConsultantEmployeeOfficer or Board MemberGrant/research supportSpeaker/honoraria includes speaker’s bureau, symposia, and expert witnessIndependent contractorExecutive role and/or ownership interestRoyalties and/or patent beneficiaryIntellectual property/patentsStock options or bond holdings in a for-profit corporation or self-directed pension planPrivate investigatorExpert witnessEquity interestOther: specify detailsNone: Has no relevant financial relationship(s) with ineligible companies to disclose.All participants that created and/or were able to influence the content and delivery of this activity reported the following disclosures. All of the relevant financial relationships listed have been mitigated. ACR Convergence 2025 On Demand Financial Relationship DisclosuresAcknowledgement of Commercial SupportNo commercial support was provided for this activity.Educational Activity PoliciesSee ACR educational activity policies, including the online enduring activity refund policy.